InnovAge Holding Corp. Increase (Decrease) in Income Taxes Receivable
InnovAge Holding Corp. (INNV) reported Increase (Decrease) in Income Taxes Receivable of -$34.00 thousand for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-09.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInIncomeTaxesReceivable · last filed 2026-09-09
- InnovAge Holding Corp. increase (decrease) in income taxes receivable for the quarter ending 2026-06-30 was -$111.00K.
- InnovAge Holding Corp. increase (decrease) in income taxes receivable for the quarter ending 2025-06-30 was -$14.00K.
- InnovAge Holding Corp. increase (decrease) in income taxes receivable for the quarter ending 2024-06-30 was -$6.00K, a 100.49% decline year-over-year.
- InnovAge Holding Corp. increase (decrease) in income taxes receivable for the quarter ending 2024-03-31 was $3.07M.
- InnovAge Holding Corp. increase (decrease) in income taxes receivable for fiscal 2026 was -$34.00K.
- InnovAge Holding Corp. increase (decrease) in income taxes receivable for fiscal 2025 was -$14.00K, a 100.46% decline from fiscal 2024.
- InnovAge Holding Corp. increase (decrease) in income taxes receivable for fiscal 2024 was $3.06M.
- InnovAge Holding Corp. increase (decrease) in income taxes receivable for fiscal 2023 was -$6.50M, a 577.87% decline from fiscal 2022.
| Period end | Increase (Decrease) in Income Taxes Receivable 3 month | Increase (Decrease) in Income Taxes Receivable 6 month | Increase (Decrease) in Income Taxes Receivable 9 month | Increase (Decrease) in Income Taxes Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$111.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-09 | -$34.00K 10-K · filed 2026-09-09 | ||
| 2026-03-31 | $77.00K 10-Q · filed 2026-05-08 | |||
| 2025-06-30 | -$14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-09 | -$14.00K 10-K · filed 2026-09-09 | ||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-08 | |||
| 2024-06-30 | -$6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-09 | $3.06M derived: sum of 2 quarters · filed 2025-09-09 | $3.06M derived: sum of 3 quarters · filed 2025-09-09 | $3.06M 10-K · filed 2025-09-09 |
| 2024-03-31 | $3.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-06 | $3.07M derived: sum of 2 quarters · filed 2025-05-06 | $3.07M 10-Q · filed 2025-05-06 | $4.30M derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-06 | $0.00 10-Q · filed 2024-02-06 | $1.23M derived: sum of 3 quarters · filed 2024-09-10 | -$3.47M derived: sum of 4 quarters · filed 2024-09-10 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-07 | $1.23M derived: sum of 2 quarters · filed 2024-09-10 | -$3.47M derived: sum of 3 quarters · filed 2024-09-10 | -$4.75M derived: sum of 4 quarters · filed 2024-09-10 |
| 2023-06-30 | $1.23M derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-10 | -$3.47M derived: sum of 2 quarters · filed 2024-09-10 | -$4.75M derived: sum of 3 quarters · filed 2024-09-10 | -$6.50M 10-K · filed 2024-09-10 |
| 2023-03-31 | -$4.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-07 | -$5.98M derived: sum of 2 quarters · filed 2024-05-07 | -$7.73M 10-Q · filed 2024-05-07 | -$6.43M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | -$1.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-06 | -$3.03M 10-Q · filed 2024-02-06 | -$1.73M derived: sum of 3 quarters · filed 2024-02-06 | -$910.00K derived: sum of 4 quarters · filed 2024-02-06 |
| 2022-09-30 | -$1.75M 10-Q · filed 2023-11-07 | -$450.00K derived: sum of 2 quarters · filed 2023-11-07 | $367.00K derived: sum of 3 quarters · filed 2023-11-07 | $1.38M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-12 | $2.12M derived: sum of 2 quarters · filed 2023-09-12 | $3.13M derived: sum of 3 quarters · filed 2023-09-12 | $1.36M 10-K · filed 2023-09-12 |
| 2022-03-31 | $817.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-09 | $1.83M derived: sum of 2 quarters · filed 2023-05-09 | $60.00K 10-Q · filed 2023-05-09 | $5.33M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $1.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-07 | -$757.00K 10-Q · filed 2023-02-07 | $4.51M derived: sum of 3 quarters · filed 2023-02-07 | $4.64M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-09-30 | -$1.77M 10-Q · filed 2022-11-08 | $3.50M derived: sum of 2 quarters · filed 2022-11-08 | $3.63M derived: sum of 3 quarters · filed 2022-11-08 | $3.39M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $5.27M derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-13 | $5.40M derived: sum of 2 quarters · filed 2022-09-13 | $5.16M derived: sum of 3 quarters · filed 2022-09-13 | $3.66M 10-K · filed 2022-09-13 |
| 2021-03-31 | $125.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-10 | -$113.00K derived: sum of 2 quarters · filed 2022-05-10 | -$1.61M 10-Q · filed 2022-05-10 | -$1.00M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | -$238.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-09 | -$1.74M 10-Q · filed 2022-02-09 | -$1.13M derived: sum of 3 quarters · filed 2022-02-09 | |
| 2020-09-30 | -$1.50M 10-Q · filed 2021-11-09 | -$890.00K derived: sum of 2 quarters · filed 2021-11-09 | ||
| 2020-06-30 | $610.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-23 | -$1.95M 10-K · filed 2021-09-23 | ||
| 2020-03-31 | -$2.56M 10-Q · filed 2021-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |